Delivery Order SPE2DB24D2100-SPE2DB25FBBQQ

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,209.24, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $10,889.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a period of performance through January 5, 2024. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,401.12 firm fixed price delivery order is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical commodity. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,580.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a performance period through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $4,493.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,568,175,951 units of epinephrine 0.3 mg auto-injectors, with a performance period ending on May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,082.90, is for the delivery of epinephrine 0.3 mg auto-injectors. It is a firm fixed-price delivery order contract with a completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.40, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract has an ultimate completion date of February 5, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.24, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. This is a firm fixed-price delivery order contract with a completion date of February 25, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083.38 Delivery Order contract is for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, with a period of performance through May 3, 2024. The contract has a Firm Fixed Price pricing type and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,856.40, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medication, with a completion date of July 7, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBQQ
    Delivery Order

This federal contract award, valued at $10,905.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies, with an ultimate completion date of January 13, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. There was no set-aside designation for this award.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:30 AM